References
- Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline: management of urticaria. Allergy. 2009;64:1427–43
- Chow S. Management of chronic urticaria in Asia: 2010 AADV consensus guidelines. Asia Pac Association Allergy Asthma Clin Immnunol. 2012;2:149–60
- Fedorowicz Z, van Zuuren E, Hu N. Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev. 2012;3:CD008596
- MŁynek A, Zalewska-Janowska A, Martus P, et al. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63:777–80
- Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy. 2009;64:1417–26
- Weldon R. Quality of life in patients with urticaria. Allergy Asthma Proc. 2006;2:96–9
- Valero A, Herdman M, Bartra J, et al. Adaptation and validation of the Spanish version of the chronic urticaria quality of life questionnaire (CU-Q2oL). J Investig Allergol Clin Immunol. 2008;18:426–32
- Aguilar-Hinojosa N, Segura-Méndez N, Lugo-Reyes S. Correlación de la gravedad de urticaria crónica y calidad de vida. Rev Alergia México. 2012;59:180–6
- Maurer M, Magerl M, Metz M, Zuberbier T. Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria. J Dtsch Dermatol Ges. 2013. [Epub ahead of print]. doi: 10.1111/ddg.12194
- Cook J, Shuster S. Lack of effect of H2 blockade in chronic urticaria. Br J Dermatol. 1979;101:21–2
- Monroe E, Cohen S, Kalbfleisch J, Schulz C. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol. 1981;117:404–7